Zenotech Laboratories Board of Directors

Get the latest insights into the leadership at Zenotech Laboratories. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Dr. Azadar Husain Asghar Mehdi Khan Non Executive Director
Mr. Jignesh Anantray Goradia Non Executive Director
Mr. Rakeshchandra Jagdishprasad Sinha Non Executive Director
Ms. Kavita Rakesh Shah Independent Director
Mr. Chintan Jitendra Shah Independent Director
Mr. Jagruti Prashant Sheth Independent Director

Zenotech Laboratories Share price

ZENOTECH

55.55

0.37 (-0.66%)
Last updated on 4 Sep, 2025 | 15:17 IST
BUYSELL
Today's High

56.78

Today's Low

55.00

52 Week Low

51.00

52 Week High

107.79

The current prices are delayed, login to your account for live prices

Zenotech Laboratories FAQs

The board at Zenotech Laboratories consists of experienced professionals, including Dr. Azadar Husain Asghar Mehdi Khan , Mr. Jignesh Anantray Goradia , and others, overseeing the company’s strategic and corporate governance.

Directors at Zenotech Laboratories are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Dr. Azadar Husain Asghar Mehdi Khan is the current chairman at Zenotech Laboratories.

Executive directors at Zenotech Laboratories are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Zenotech Laboratories adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Zenotech Laboratories, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.